![Adam Knight](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adam Knight
Consultant / Advisor chez
Perceptive Advisors (Private Equity)
Profil
Adam Knight was the founder of Neuron23, Inc. which was founded in 2017, where he held the title of Chief Business Officer from 2017 to 2023.
Currently, he is an Advisor at Perceptive Advisors (Private Equity) since 2022 and a Strategic Advisor at Soda Health, Inc. since 2021.
He previously worked as a Scientific Advisor at eFFECTOR Therapeutics, Inc. Dr. Knight received his doctorate degree from the University of Cambridge in 2015, his graduate degree from The University of Alabama School of Medicine in 2011, and his undergraduate degree from The University of Alabama School of Medicine in 2009.
Postes actifs de Adam Knight
| Sociétés | Poste | Début |
|---|---|---|
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Consultant / Advisor | 01/02/2022 |
Soda Health, Inc.
 Soda Health, Inc. Internet Software/ServicesTechnology Services Operates as a healthcare technology platform | Consultant / Advisor | 01/04/2021 |
Anciens postes connus de Adam Knight
| Sociétés | Poste | Fin |
|---|---|---|
Neuron23, Inc.
 Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Fondateur | 22/08/2023 |
| EFFECTOR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Adam Knight
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
42
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Alabama School of Medicine
 The University of Alabama School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in both public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It participates in seed, early, later stage and growth transactions in the form of equity and debt with an investment size of USD 10 – 300 million. The firm acts as lead investor and takes a seat on a board of directors. | Finance |
Neuron23, Inc.
Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Commercial Services |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Soda Health, Inc.
Soda Health, Inc. Internet Software/ServicesTechnology Services Operates as a healthcare technology platform | Technology Services |
